Replacing invasive tissue biopsies with advanced non-invasive diagnostic tools is accelerating clinical development and trial timelines across metabolic dysfunction-associated steatohepatitis (MASH) programs. Detailed analysis within the Fibrotic Diseases Treatment Market report highlights how transient elastography (FibroScan), magnetic resonance elastography (MRE), and circulating serum...